Y Mabs Therapeutics Inc (YMAB) Inventory Turnover Ratio, from second quarter 2025 to second quarter 2024, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Y mabs Therapeutics inc   (NASDAQ: YMAB)
 

Y Mabs Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2025, Y Mabs Therapeutics Inc 's inventory turnover ratio sequentially decreased to 1.73 in the second quarter 2025, otherwise the ratio remained above the average, as YMAB's markets remain strong.Y Mabs Therapeutics Inc 's average inventory processing period in the Jun 30 2025 quarter, has increased to 211 days, from 191 days, in the Mar 31 2025 quarter.

Within Healthcare sector 247 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1031 in the first quarter 2025, to 1445.

YMAB Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Y Mabs Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

YMAB Inventory Turnover Ratio (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Inventory Growth 14.37 % -5.36 % 42.43 % 34.36 % 63.83 %
Y / Y Cost of Sales Growth -33.64 % 43.06 % 274.74 % -13.37 % -35.17 %
Inventory Turnover Ratio (TTM) 1.73 1.91 1.78 1.19 1.34
YMAB's Total Ranking # 1445 # 1031 # 1033 # 1084 # 1120
Average inventory processing period 211 191 205 307 273
Seq. Inventory Growth 21.56 % 10.83 % -24.52 % 12.46 % 0.59 %
Seq. Cost of Sales Growth -33.33 % -60.74 % 239.9 % -25.41 % 43.73 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 76
Healthcare Sector # 248
Overall Market # 1445

Inventory Turnover Ratio Statistics
High Average Low
1.91 1.36 0.61
(Mar 31 2025)   (Dec 31 2021)



YMAB Company Profile >> Back to YMAB Efficiency Comparisons >> Compare YMAB Inventory Turnover Ratio to its Competitors

Financial Statements
Y Mabs Therapeutics Inc 's Inventories $ 10 Millions Visit YMAB's Balance sheet
Y Mabs Therapeutics Inc 's Cost of Revenues TTM $ 15 Millions Visit YMAB's Income Statement
What are YMAB's Sales? Visit YMAB's Sales by Segment

Other Inventory Turnover Ratios
Y Mabs Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
YMAB's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for YMAB's Competitors
Inventory Turnover Ratio for YMAB's Suppliers
Inventory Turnover Ratio for YMAB's Customers

You may also want to know
YMAB's Sales Growth Rates YMAB's Pe Price to earnings ratio YMAB's Receivables Turnover Ratio YMAB's Stock Quote
YMAB's Net Income Growth Rates YMAB's Ps Price to Sales ratio YMAB's Sales per Employee YMAB's Asset Turnover Ratio
YMAB's Net Margin YMAB's Pb Price to Book ratio YMAB's Financial Strength Ratios YMAB's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2025 Inventories at quarter ending Jun 30 2025
Insight Molecular Diagnostics Inc   4.21 $ 1.886  Millions$ 0  Millions
Electromed Inc   4.18 $ 14.000  Millions$ 3  Millions
Teva Pharmaceutical Industries Limited  4.14 $ 8,381.000  Millions$ 2,025  Millions
Catalyst Pharmaceuticals Inc   4.07 $ 79.445  Millions$ 19  Millions
Alpha Teknova Inc   4.05 $ 29.000  Millions$ 7  Millions
Guardant Health Inc   4.04 $ 308.010  Millions$ 76  Millions
Celularity Inc   4.01 $ 20.022  Millions$ 5  Millions
Idexx Laboratories Inc  3.99 $ 1,554.890  Millions$ 390  Millions
Tactile Systems Technology Inc   3.96 $ 75.000  Millions$ 19  Millions
Ge Healthcare Technologies Inc   3.94 $ 8,382.000  Millions$ 2,126  Millions
Vericel Corporation  3.94 $ 66.081  Millions$ 17  Millions
Koru Medical Systems Inc   3.89 $ 13.578  Millions$ 3  Millions
Novocure Limited  3.87 $ 148.831  Millions$ 38  Millions
Dynatronics Corporation  3.79 $ 21.382  Millions$ 6  Millions
Indivior Pharmaceuticals Inc   3.76 $ 393.000  Millions$ 105  Millions
Abbvie Inc   3.74 $ 16,956.000  Millions$ 4,529  Millions
Iovance Biotherapeutics inc   3.73 $ 191.771  Millions$ 51  Millions
Zeo Scientifix Inc   3.71 $ 0.900  Millions$ 0  Millions
3m Company  3.70 $ 14,515.000  Millions$ 3,921  Millions
Solventum Corporation  3.65 $ 3,324.000  Millions$ 910  Millions
Blue Water Vaccines Inc  3.60 $ 0.445  Millions$ 0  Millions
Escalon Medical Corp   3.58 $ 6.535  Millions$ 2  Millions
Rigel Pharmaceuticals Inc  3.51 $ 22.728  Millions$ 6  Millions
Cadre Holdings inc   3.47 $ 332.797  Millions$ 96  Millions
Gilead Sciences Inc   3.46 $ 6,196.000  Millions$ 1,791  Millions
Myomo Inc   3.42 $ 12.000  Millions$ 4  Millions
Exelixis Inc   3.31 $ 75.935  Millions$ 23  Millions
Prestige Consumer Healthcare Inc   3.30 $ 491.000  Millions$ 149  Millions
Biofrontera Inc   3.26 $ 19.364  Millions$ 6  Millions
Agilent Technologies inc   3.26 $ 3,219.000  Millions$ 987  Millions

Date modified: 2026-08-29T17:41:26+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.